在免疫媒介炎症疾病中,COVID-19疫苗接种和免疫抑制疗法
José M Serra López-Matencio1, Esther F Vicente-Rabaneda2, Estefanía Alañón1
1Hospital Pharmacy Service, Hospital Universitario de La Princesa, IIS-Princesa, 28006 Madrid, Spain.
Vaccines
|December 23, 2023
概括
接受免疫抑制疗法的免疫媒介性炎症性疾病 (IMID) 患者可能对COVID-19疫苗的反应降低. 暂时停止免疫抑制剂可能会改善疫苗反应,但需要进一步指导.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 药理学 药理学是指药理学的学科.
背景情况:
- COVID-19疫苗接种计划带来了前所未有的后勤挑战.
- 接受免疫抑制疗法的免疫媒介性炎症性疾病 (IMID) 患者需要特别注意,因为疫苗反应的潜在不确定性.
- 现有证据表明,免疫抑制疗法可以损害对其他疫苗 (如流感,肺炎球菌) 的幽默反应.
研究的目的:
- 审查目前关于免疫抑制剂对IMID患者COVID-19疫苗反应的影响的证据.
- 为免疫抑制疗法IMID患者接种疫苗的管理算法提出建议.
主要方法:
- 对现有科学文献进行系统审查.
- 对研究免疫抑制药物对COVID-19疫苗免疫性影响的研究进行分析.
- 基于收集的证据,制定临床管理策略.
主要成果:
- 一些研究表明,在接种疫苗后的两周内暂时停止使用甲状腺素,可能会增强疫苗的反应.
- 对各种免疫抑制药物的研究正在进行中,但最佳的管理策略仍然不清楚.
- 免疫抑制剂对IMID患者COVID-19疫苗反应的影响是研究的一个关键领域.
结论:
- 进一步的研究是必不可少的,以澄清免疫抑制治疗对IMID患者COVID-19疫苗疗效的影响.
- 需要一个明确的管理协议,以优化针对这个脆弱群体的疫苗接种策略.
- 为了控制疾病,平衡免疫抑制与最大限度地提高疫苗诱导的免疫力是一个关键的挑战.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
168
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
168
Immunodeficiency Diseases
945
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
945
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Pulmonary Tuberculosis I
244
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
141
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
141
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
121
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
121


